It acts directly on neighboring -cells to inhibit the secretion of glucagon and can also indirectly influence -cells by inhibiting the secretion of other hormones.243 In the local islet environment, a high concentration of somatostatin creates an inhibitory milieu, further reducing the activity of -cells and the secretion of glucagon.244 Additionally, somatostatin can inhibit gastrointestinal activity, reducing the secretion of pancreatic enzymes and gastric acid, thereby indirectly decreasing the demand for glucagon.245,246 Hence, GLP-1 activates -cells and promotes somatostatin secretion, forming a multi-layered inhibitory mechanism that effectively reduces glucagon secretion
Get Free Access to Demo Report, Excel Pivot and ToC: Glucagon-like peptide-1 (GLP-1) is an endogenous incretin hormone secreted by the gastrointestinal tract, playing a critical role in the regulation of glucose homeostasis and appetite
Safety Guardrails and Who Should Avoid Fasting on GLP-1 Patients with Type 1 or Type 2 diabetes, a history of eating disorders, cardiovascular disease, or those taking additional glucose-lowering medications should consult their provider before any fasting protocol on GLP-1 therapy
PMCID: PMC5579659
Shenzhen, China July 21, 2025 Liposomal Glutathione, a next-generation antioxidant ingredient, is gaining widespread recognition in the dietary supplement industry for its enhanced bioavailability, superior absorption, and advanced cellular protection